Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).
本发明揭示了具有
吡唑吡啶基础结构的公式(1.0)的ERK
抑制剂及其药学上可接受的盐。本发明还揭示了使用公式(1.0)的化合物治疗癌症的方法。